Jane Street
DNA icon

Jane Street’s Ginkgo Bioworks DNA Stock Holding History

Jane Street’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$203K Buy
+15,800
New +$129K ﹤0.01% 10052
2025
Q4 		– Sell
-15,100
Closed -$220K – 11370
2025
Q3 		$220K Buy
+15,100
New +$181K ﹤0.01% 9489
2025
Q2 		– Sell
-17,600
Closed -$100K – 9862
2025
Q1 		$100K Sell
17,600
-14,600
-45% -$149K ﹤0.01% 8805
2024
Q4 		$316K Buy
32,200
+18,000
+127% +$154K ﹤0.01% 7647
2024
Q3 		$116K Buy
14,200
+13,760
+3,127% +$138K ﹤0.01% 8937
2024
Q2 		$5.88K Sell
440
-15
-3% -$448 ﹤0.01% 9152
2024
Q1 		$21.1K Sell
455
-1,008
-69% -$52.2K ﹤0.01% 8894
2023
Q4 		$98.9K Sell
1,463
-367
-20% -$22.5K ﹤0.01% 8584
2023
Q3 		$132K Sell
1,830
-1,008
-36% -$80.6K ﹤0.01% 7845
2023
Q2 		$211K Buy
2,838
+323
+13% +$19.1K ﹤0.01% 7623
2023
Q1 		$134K Sell
2,515
-750
-23% -$47.5K ﹤0.01% 8075
2022
Q4 		$221K Sell
3,265
-5,255
-62% -$483K ﹤0.01% 7522
2022
Q3 		$1.06M Buy
8,520
+4,437
+109% +$529K ﹤0.01% 5306
2022
Q2 		$389K Sell
4,083
-9,647
-70% -$1.18M ﹤0.01% 7174
2022
Q1 		$2.21M Buy
13,730
+3,365
+32% +$655K ﹤0.01% 4566
2021
Q4 		$3.44M Buy
10,365
+4,437
+75% +$2.11M ﹤0.01% 3458
2021
Q3 		$2.75M Buy
+5,928
New +$2.89M ﹤0.01% 3834

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
J.M. Forbes & Co
J.M. Forbes & Co Boston, Massachusetts $1.33B AUM 21.14% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Jane Street's DNA Position: Q3 2026 in Review

Jane Street opened a new position in Ginkgo Bioworks (DNA) in Q3 2026: 25,096 shares worth $322K. The stake represents ﹤0.01% of the portfolio and ranks #9015 among its holdings. This is a return to the name: Jane Street previously reported a position in DNA as recently as Q4 2025.

Jane Street first reported a position in DNA in Q3 2021 and has held it in 16 quarters since. The position peaked at $6.17M in Q4 2023. 100 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Jane Street held 25,096 shares of Ginkgo Bioworks worth $322K as of Q3 2026.
  • Ginkgo Bioworks was a new Jane Street position in Q3 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #9015 holding.
  • Jane Street first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 16 quarters since.
  • Jane Street's Ginkgo Bioworks position peaked at $6.17M in Q4 2023.
  • 100 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.